Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04474795 · ClinicalTrials.gov registry record · NA

Clinic to Community Connections - Broader Distribution

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
85
Enrollment target

NCT04474795: Completed NA study, sponsored by Washington University School of Medicine.

NCT04474795 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 85 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04474795, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
85 participants
Enrollment target

Study Summary

This study addresses education needs in gestational diabetes care and followup at the staff and patient levels. In the initial phase, nurses and community health workers will complete specific training modules on gestational diabetes developed for this study. The effectiveness of the education modules will be evaluated through pre/post surveys of participants assessing diabetes knowledge, attitudes, and self-efficacy.

Primary Outcome

Pre-Post change in staff participants' perceived self-efficacy to provide diabetes education (Mean score min:1 max 10) high score=more confident

Interventions

  • BEHAVIORAL Staff -Educational training

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2020-06-18
Est. Completion 2022-08-22
Phase NA

What the finished NCT04474795 record still lists

NCT04474795 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which Staff -Educational training is the first listed.

NCT04474795 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04474795 about?

NCT04474795 is a clinical study titled "Clinic to Community Connections - Broader Distribution". This study addresses education needs in gestational diabetes care and followup at the staff and patient levels. In the initial phase, nurses and community health workers will complete specific training modules on gestational diabetes developed for this study. The effectiveness of the education modu...

What is the current status of trial NCT04474795?

This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2020-06-18. Estimated completion is 2022-08-22.

What interventions are being tested in trial NCT04474795?

The interventions under investigation include: Staff -Educational training (BEHAVIORAL).

Who is sponsoring clinical trial NCT04474795?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04474795's enrollment target sits among peer trials

85 980th of 2000 higher than 1,018 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00842283 · 85 participants

    Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target

  • NCT02133196 · 85 participants · Phase 2

    T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

  • NCT03823144 · 85 participants · NA

    Intravital Microscopy in Human Solid Tumors

  • NCT03875638 · 85 participants · Phase 2

    Treating Hyperexcitability in AD With Levetiracetam

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04474795, the US trial registry maintained by the National Library of Medicine. NCT04474795 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.